{"title":"从JAK3基因突变患者中产生iPSC系(CHSUi001-A)","authors":"Meng Gao , Na Li , Xingcui Wang","doi":"10.1016/j.scr.2025.103822","DOIUrl":null,"url":null,"abstract":"<div><div>This study describes the establishment of an induced pluripotent stem cell (iPSC) line derived from a patient harboring two heterozygous <em>JAK3</em> gene mutations: c.1914G > T and c.1048C > T. The iPSCs were generated via non-integrating episomal vector-mediated reprogramming of peripheral blood mononuclear cells (PBMCs), expressing OCT4, SOX2, KLF4, BCL-XL and c-MYC. The resulting iPSCs exhibited robust expression of pluripotency markers, demonstrated trilineage differentiation potential in vitro, and maintained a normal karyotype. This iPSC line serves as a valuable resource for elucidating the molecular mechanisms underlying JAK3-associated immunodeficiencies and for preclinical drug screening.</div></div>","PeriodicalId":21843,"journal":{"name":"Stem cell research","volume":"88 ","pages":"Article 103822"},"PeriodicalIF":0.7000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generation of an iPSC line (CHSUi001-A) from a patient with JAK3 gene mutations\",\"authors\":\"Meng Gao , Na Li , Xingcui Wang\",\"doi\":\"10.1016/j.scr.2025.103822\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This study describes the establishment of an induced pluripotent stem cell (iPSC) line derived from a patient harboring two heterozygous <em>JAK3</em> gene mutations: c.1914G > T and c.1048C > T. The iPSCs were generated via non-integrating episomal vector-mediated reprogramming of peripheral blood mononuclear cells (PBMCs), expressing OCT4, SOX2, KLF4, BCL-XL and c-MYC. The resulting iPSCs exhibited robust expression of pluripotency markers, demonstrated trilineage differentiation potential in vitro, and maintained a normal karyotype. This iPSC line serves as a valuable resource for elucidating the molecular mechanisms underlying JAK3-associated immunodeficiencies and for preclinical drug screening.</div></div>\",\"PeriodicalId\":21843,\"journal\":{\"name\":\"Stem cell research\",\"volume\":\"88 \",\"pages\":\"Article 103822\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem cell research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1873506125001722\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem cell research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1873506125001722","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Generation of an iPSC line (CHSUi001-A) from a patient with JAK3 gene mutations
This study describes the establishment of an induced pluripotent stem cell (iPSC) line derived from a patient harboring two heterozygous JAK3 gene mutations: c.1914G > T and c.1048C > T. The iPSCs were generated via non-integrating episomal vector-mediated reprogramming of peripheral blood mononuclear cells (PBMCs), expressing OCT4, SOX2, KLF4, BCL-XL and c-MYC. The resulting iPSCs exhibited robust expression of pluripotency markers, demonstrated trilineage differentiation potential in vitro, and maintained a normal karyotype. This iPSC line serves as a valuable resource for elucidating the molecular mechanisms underlying JAK3-associated immunodeficiencies and for preclinical drug screening.
期刊介绍:
Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem cell research. Submissions to Stem Cell Research, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, stem cell genomes, and translational research. Stem Cell Research publishes 6 issues a year.